Recombinant Pongo pygmaeus Ribonuclease 8 (RNASE8)

Shipped with Ice Packs
In Stock

Description

Molecular Structure and Expression

RNASE8 retains the canonical structural features of RNase A superfamily members, including:

  • Signal peptide: A 27-amino-acid N-terminal signal peptide for secretion .

  • Catalytic residues: A lysine (K) and two histidines (H) forming the catalytic triad, alongside eight cysteines for disulfide bonding .

  • Signature motif: The conserved "CKXXNTF" region critical for enzymatic activity .

Phylogenetic Relationships

  • RNASE8 originated from a gene duplication event in primates, with RNase7 as its closest homolog (78% sequence identity) .

  • Comparative analysis of 10 primate species revealed that RNase8 genes in 60% of examined species (including P. pygmaeus) are pseudogenized due to frameshift mutations or critical residue substitutions .

Functional Diversification

  • Human RNase8 exhibits low ribonucleolytic activity compared to other RNase A superfamily members (e.g., RNases 1–3, 6, 7) .

  • Its tissue-specific expression (placenta-only) and rapid evolution suggest a specialized role in pregnancy or fetal development .

Production Methods

Recombinant RNASE8 is typically expressed in bacterial systems (e.g., E. coli) using vectors like pFLAG CTS, which appends a FLAG tag for purification . The protein is purified via affinity chromatography and quantified by Western blotting .

Enzymatic Activity

SpeciesRibonucleolytic ActivityRelative ActivityCitations
Human RNase8~1.0 pmol<10% of RNase1
Owl Monkey EDN~0.1 pmol~30% of human EDN
Recombinant RNase8N/APredicted low activity

Potential Applications

  • Host defense: RNase A superfamily proteins (e.g., RNase7) exhibit antibacterial and antiviral activities, suggesting RNASE8 may have analogous roles .

  • Reproductive biology: Placental expression patterns imply a role in pregnancy, potentially linked to maternal-fetal immune interactions .

Product Specs

Form
Lyophilized powder. We will ship the format in stock, but if you have special format requirements, please note them when ordering and we will fulfill your request.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form shelf life is generally 6 months at -20°C/-80°C. Lyophilized form shelf life is generally 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
RNASE8; Ribonuclease 8; RNase 8; EC 3.1.27.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
28-154
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Pongo pygmaeus (Bornean orangutan)
Target Names
RNASE8
Target Protein Sequence
KPK DMTSSQWLKT QHMQPSPQAC NSAMNNINKY TEQCKDLNTF LHELFSSVAT TCQTPNIACK NSRKNCHQSH GPMSLTMCEL TSGKYPNCRY KEKHLNAPYI AACDPPQQGD PGYPLVPVHL DKVV
Uniprot No.

Target Background

Function
Exhibits low ribonuclease activity.
Protein Families
Pancreatic ribonuclease family
Subcellular Location
Secreted.

Q&A

What is the evolutionary significance of RNASE8 in primates?

Ribonuclease 8 belongs to the RNase A family of secretory ribonucleases, with orthologs found exclusively in primate genomes. This makes RNASE8 particularly interesting from an evolutionary perspective as it represents a relatively recent development in the RNase A family. RNASE8 is a divergent paralog of RNase 7, which is known to be lysine-enriched, highly conserved, and possesses prominent antimicrobial activity . When conducting comparative genomic studies, researchers should consider analyzing RNASE8 sequences from various primates including humans, chimpanzees (Pan troglodytes), gorillas (Gorilla gorilla), orangutans (Pongo pygmaeus), and baboons (Papio hamadryas) to understand evolutionary patterns and functional divergence .

What is known about the genetic diversity of RNASE8 in humans?

Analysis of human RNASE8 genetic diversity has revealed only two single-nucleotide polymorphisms and four unique alleles within the coding sequence. The nucleotide sequence diversity (π = 0.00122 ± 0.00009 per site) is unremarkable for a human nuclear gene . When studying genetic variation, researchers should consider amplifying the 688 bp genomic fragment encompassing the RNASE8 open reading frame using gene-specific primers (like RN8F and RN8R primers), followed by bidirectional sequencing with BigDye terminator technology . Heterozygosity can be confirmed and resolved by cloning amplification products into TA vectors and re-sequencing.

What unique structural features distinguish RNASE8 from other RNase A family members?

RNASE8 exhibits a particularly interesting structural feature that breaks the paradigm for prototypical RNase A ribonucleases. Research has identified a distal translational start site followed by sequence encoding an additional 30 amino acids that are conserved in several higher primates . Unlike typical RNase A family members which possess hydrophobic signal sequences directing them through ER/Golgi for post-translational processing, the extended amino terminus of RNASE8 (amino acids 1-31) has a predominantly hydrophilic nature . This suggests that RNASE8 with this extension may not function as a traditional secretory protein, representing a significant structural divergence within the RNase A family.

How can researchers verify proper protein folding and disulfide bridge formation in recombinant RNASE8?

Mass spectrometry analysis using electrospray ionization methods is essential for verifying proper folding and disulfide bridge formation. For example, mass analysis of purified RNase 8 yielded a mass of 14,201.4 Da, which is 8 Da less than the theoretical mass calculated from the deduced amino acid sequence (14,209.3 kDa), suggesting that the eight cysteyl residues are connected through four disulfide bridges . Researchers should implement this verification step after purification to ensure biological activity, as incorrect disulfide pairing could significantly impact functional studies.

What expression systems are optimal for producing functional recombinant RNASE8?

The yeast expression system has proven to be the most economical and efficient eukaryotic system for RNASE8 production . For research requiring high protein quality closely resembling the natural protein, mammalian cell systems can be considered, though they present challenges of lower expression levels, higher medium costs, and more complex culture conditions . When expressing RNASE8 in bacterial systems like E. coli, researchers have successfully used the expression vector pQE-2 to generate fusion proteins containing an N-terminal His tag sequence, allowing purification via nickel affinity chromatography .

What is the recommended purification protocol for isolating high-purity recombinant RNASE8?

A robust purification protocol for His-tagged RNASE8 involves:

  • Initial capture using nickel affinity chromatography (Macherey-Nagel or similar columns)

  • Further purification by C8 reversed-phase high-pressure liquid chromatography (HPLC)

  • If necessary, cleavage of the N-terminal fusion tag using dipeptidyl aminopeptidase I

  • Final purification of the mature RNASE8 protein by C2/C18 reversed-phase HPLC

This multi-step approach consistently yields protein with >90% purity, suitable for functional and structural studies .

How should researchers approach cloning and amplification of RNASE8 from primate genomic DNA?

For successful amplification of RNASE8 from primate genomic DNA, a nested PCR approach is recommended:

  • First-round amplification using primers 5'-R8F and 3'-R8R with 0.5 μg of gDNA and high-fidelity polymerase (e.g., Titanium Taq)

  • Thermal cycling: 95°C for 1 min followed by 30 cycles of 95°C for 30 sec, 68°C for 1.5 min, and 68°C for 3 min

  • Second nested amplification with primers 5'-R8Fn and 3'-R8Rn to generate a ~625 bp product

  • Clone amplification products into a suitable vector (e.g., TA 2.1 vector)

  • Sequence multiple clones bidirectionally using standard sequencing technology

This approach accounts for potential sequence variations between species and ensures high-quality sequence data.

What evidence supports antimicrobial activity of RNASE8?

The high similarity of RNASE8 to the antimicrobially active RNase 7 suggests that RNASE8 might also function as an antimicrobial protein . Experimental evidence has demonstrated that recombinant RNASE8 exhibits antimicrobial activity against microorganisms such as Escherichia coli. The high activity observed indicates that this antimicrobial protein could contribute to innate immunity and may help protect the body from infection . Researchers investigating this property should consider comparative studies with other antimicrobial RNases to determine mechanistic similarities and differences.

What methodology should be used to assess the antimicrobial activity of RNASE8?

To rigorously assess antimicrobial activity of RNASE8, researchers should:

  • Prepare microbial suspensions (approximately 10⁴ to 10⁵ microorganisms/ml)

  • Mix 100 μl of the microbial suspension with 10 μl of RNASE8 dissolved in 10 mM sodium phosphate buffer (pH 7.4)

  • Test a concentration range of RNASE8 (0.001 to 7 μM is recommended)

  • Incubate at 37°C for 2 hours

  • Analyze antimicrobial activity using standard microbiological methods

This protocol allows for determination of both antimicrobial efficacy and minimum inhibitory concentrations against various pathogens.

How might the extended N-terminus of RNASE8 impact its function?

The discovery of an extended N-terminus in RNASE8 with predominantly hydrophilic properties (in contrast to the hydrophobic signal sequences typical of RNase A family members) suggests that RNASE8 may have evolved novel functions . Experiments comparing constructs with and without this N-terminal extension have shown that the natural construct including the distal translational start site promotes only minimal activity . This observation indicates that this region might be involved in regulatory mechanisms affecting RNASE8 function or could direct the protein to different cellular compartments. Researchers should design experiments specifically addressing the role of this unique region to fully understand RNASE8 functional divergence.

What techniques can overcome challenges in detecting endogenous RNASE8 expression?

Despite significant efforts and the development of specific anti-peptide antibodies, researchers have struggled to detect expression of RNASE8 polypeptide in human fibroblast or hematopoietic cell lines . To address this challenge, investigators should consider:

  • Developing highly sensitive detection methods beyond conventional Western blotting

  • Exploring conditions that might upregulate RNASE8 expression, such as immune stimulation or stress conditions

  • Utilizing more sensitive transcriptional analysis methods, including digital PCR or RNA-seq with deep coverage

  • Employing reporter systems fused to the RNASE8 promoter to track expression patterns in different cellular contexts

  • Considering tissue-specific expression analyses focusing on lung, spleen, and testis where expression has been detected

How should researchers approach the functional divergence hypothesis for RNASE8?

The observation that RNASE8 may be under constraints promoting selection of a novel function requires careful experimental design:

  • Compare ribonucleolytic activity of RNASE8 with other RNase A family members using standardized substrates

  • Test RNASE8 against various RNA species to identify potential substrate preferences

  • Investigate potential protein-protein interactions that might suggest non-canonical functions

  • Design chimeric proteins swapping domains between RNASE8 and other RNases to identify regions responsible for functional differences

  • Consider evolutionary analyses comparing selection patterns across primate lineages

These approaches can help determine whether RNASE8 has indeed evolved novel functions beyond the canonical RNA degradation activity of the RNase A family.

What insights might be gained from studying "functional pseudogenes" of RNASE8 in non-human primates?

The concept of "functional pseudogenes" in the context of RNASE8 represents coding sequences that appear intact but contain mutations in elements crucial for ribonucleolytic activity . Researchers investigating these variants should:

  • Perform comprehensive comparative genomic analyses across diverse primate species

  • Express and functionally characterize these apparent pseudogenes to determine whether they retain alternative activities

  • Investigate species-specific expression patterns that might suggest adaptive roles

  • Consider the possibility that these variants represent proteins responding to different selective pressures

  • Use molecular evolutionary analyses to identify signatures of positive selection or relaxed constraints in different lineages

This research direction may reveal fundamental insights into protein evolution and functional innovation.

How can recombinant RNASE8 be utilized in immunological research?

Given its potential antimicrobial properties, recombinant RNASE8 can serve as a valuable tool in immunological research:

  • As a positive control in antimicrobial assays against various pathogens

  • For studying innate immune mechanisms in primates

  • As a comparative model when investigating other antimicrobial proteins

  • For developing novel antimicrobial therapies based on naturally occurring immune molecules

  • In structure-function studies to identify key regions responsible for antimicrobial activity

Researchers should consider obtaining highly purified recombinant RNASE8 with verified activity for these applications.

What considerations are important when designing mutational studies of RNASE8?

When designing mutational studies to investigate structure-function relationships in RNASE8:

  • Focus on the catalytic triad analogous to other RNase A family members

  • Consider the eight conserved cysteyl residues involved in disulfide bridge formation

  • Examine the unique extended N-terminal region and its impact on function

  • Create systematic alanine scanning mutations to identify functional hotspots

  • Design chimeric constructs exchanging domains between RNASE8 and related RNases

  • Verify proper folding of mutant proteins using mass spectrometry to confirm disulfide bridge formation

These approaches can provide insights into both conserved mechanisms and unique features of RNASE8.

What controls and standards should be included in RNASE8 functional assays?

To ensure rigorous and reproducible results in RNASE8 functional studies:

  • Include well-characterized RNase A as a positive control for ribonucleolytic assays

  • Use RNase 7 as a comparative control for antimicrobial activity assays

  • Include protein concentration standards and enzymatic activity references

  • Employ multiple methodologies to assess activity (e.g., spectrophotometric assays, zymograms, fluorogenic substrates)

  • Include negative controls such as heat-inactivated enzymes or catalytically inactive mutants

  • Verify protein purity (>90%) and proper folding before functional testing

These controls help establish reliable assay systems for investigating RNASE8 functions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.